Coxibren 90 Tablet is primarily utilised for the management of pain and inflammation associated with various conditions, including arthritis and postoperative pain. It belongs to the class of medicines known as COX-2 inhibitors.
Coxibren 90 Tablet is prescribed for:
• Managing pain and inflammation related to osteoarthritis
• Reducing symptoms in rheumatoid arthritis
• Addressing ankylosing spondylitis, a specific type of spinal arthritis
• Alleviating severe joint inflammation in acute gouty arthritis
• Providing relief from postoperative dental pain
• Mitigating symptoms of primary dysmenorrhoea, commonly termed as menstrual cramps
• Swallow the tablet whole with a glass of water.
• Avoid crushing or chewing the tablet.
• Adhere strictly to the prescribed dosage, and do not exceed it without consulting your doctor.
• Do not discontinue the medication without prior consultation with your doctor.
Coxibren 90 Tablet is taken orally.
The side effects associated with Coxibren 90 Tablet may include:
• Abdominal pain
• Diarrhoea
• Fatigue
• Dyspepsia (indigestion)
• Flatulence or excessive gas
Coxibren 90 Tablet contains etoricoxib (90 mg), which functions as follows:
• Blocks COX-2 Enzyme: It inhibits the cyclooxygenase-2 (COX-2) enzyme in the body. This enzyme is crucial in the biosynthesis of prostaglandins, which are compounds involved in pain and inflammation pathways.
• Reduces Pain and Inflammation: By blocking COX-2, etoricoxib aids in decreasing these symptoms, offering relief from conditions characterised by pain and inflammation.
This medicine is contraindicated during pregnancy.
It is advisable to consult your doctor before using Coxibren 90 Tablet while breastfeeding.
Alcohol consumption may elevate the risk of gastrointestinal bleeding with this medication. Avoid alcohol intake while on Coxibren 90 Tablet.
Patients with liver conditions should use Coxibren 90 Tablet with caution and under medical supervision to avoid exacerbation of liver issues.
If you have kidney problems, use Coxibren 90 Tablet with caution and under medical supervision.
Coxibren 90 Tablet may cause dizziness or somnolence; therefore, avoid operating machinery or driving.
Avoid taking this medicine if you have a known allergy to etoricoxib or any of its constituents.
Coxibren 90 Tablet is not recommended for individuals under 16 years of age.
Older patients may be more susceptible to the side effects of Coxibren 90 Tablet and should therefore be closely monitored.
Drug-Drug Interactions
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): The concurrent use with Coxibren 90 Tablet may increase the risk of gastrointestinal ulcers or bleeding.
• Blood Pressure Medicines: These may have altered efficacy when taken alongside Coxibren 90 Tablet.
• Anticoagulants: There is a potential increased risk of bleeding when used with this medicine.
Drug-Disease Interactions
• Heart Disease: Patients with heart disease should exercise caution as this medicine may increase cardiovascular risk.
Daily Dosage
• Take Coxibren 90 Tablet as directed by your doctor. The dosage is contingent on the severity of the condition and individual response. It is important to follow the prescribed dosage and not exceed it without consulting your doctor.
Missed Dose
• If you miss a dose, take it as soon as you remember. However, if it is almost time for the next dose, skip the missed dose. Do not double the dose.
Overdose
• Overdose symptoms may include nausea, vomiting, drowsiness, or stomach discomfort. Seek medical attention if an overdose is suspected.
• Store Coxibren 90 Tablet at a temperature not exceeding 30°C.
• Keep it away from direct light and moisture.
• Ensure that it is kept out of reach of children.
• Check the expiry date before using the product.
• Incorporate foods rich in omega-3 fatty acids, such as fish, walnuts, and flaxseeds, which have anti-inflammatory properties.
• Engage in regular exercise like swimming or walking to improve joint mobility and overall health. Seek your doctor's guidance before starting any new exercise routine.
.avif)
%20(1).png)
.webp)